on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health Schedules Investor Webcast on Q4 2025 Financials
Jaguar Health, Inc. has announced a webcast for investors set for April 10, 2026, at 8:30 a.m. Eastern. The presentation will cover financials from the fourth quarter of 2025 and provide company updates. Interested participants can register through the company's website.
The webcast will include information on Jaguar's subsidiaries, Napo Pharmaceuticals and Napo Therapeutics, which develop treatments for rare gastrointestinal disorders. Additionally, Magdalena Biosciences, a joint venture with Filament Health Corp., focuses on plant-derived prescription medicines for mental health issues.
Jaguar highlights forward-looking statements in the press release, emphasizing that they rest on current expectations and are not guaranteed outcomes. These projections may be affected by unpredictable risks and uncertainties.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news